ORGENTEC Diagnostika GmbH Sustainability Profile
ORGENTEC Diagnostika GmbH, headquartered in Germany, is a leading player in the field of medical diagnostics, specialising in autoimmune and infectious disease testing. Founded in 1988, the company has established a strong presence in Europe and beyond, providing innovative solutions that enhance laboratory efficiency and accuracy. With a diverse portfolio of products, ORGENTEC offers unique diagnostic kits and reagents that stand out for their reliability and precision. The company is particularly renowned for its expertise in enzyme immunoassays and molecular diagnostics, catering to the needs of healthcare professionals worldwide. Recognised for its commitment to quality and innovation, ORGENTEC has achieved significant milestones, solidifying its position as a trusted partner in the diagnostics industry. Through continuous research and development, ORGENTEC remains at the forefront of advancements in medical technology, contributing to improved patient outcomes globally.
DitchCarbon Score
How does ORGENTEC Diagnostika GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ORGENTEC Diagnostika GmbH's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ORGENTEC Diagnostika GmbH's reported carbon emissions
ORGENTEC Diagnostika GmbH, headquartered in Germany, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary and does not inherit emissions data from a parent organization. Despite the lack of specific emissions data, ORGENTEC has not outlined any formal reduction targets or climate commitments, such as those typically associated with the Science Based Targets initiative (SBTi) or other climate pledges. This suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, many organisations are increasingly focusing on sustainability and carbon reduction initiatives. As ORGENTEC navigates its climate commitments, it may consider aligning with industry standards and best practices to enhance its environmental impact and transparency.
How Carbon Intensive is ORGENTEC Diagnostika GmbH's Industry?
How Carbon Intensive is ORGENTEC Diagnostika GmbH's Location?
ORGENTEC Diagnostika GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ORGENTEC Diagnostika GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
